Stock listing
I76 Stock Price, News, Filings & Events — Ironwood Pharmaceuticals, Inc.
Selected listing: I76 · BX · CHF · CH
This page tracks Ironwood Pharmaceuticals, Inc.'s I76:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following I76:BX. I76:BX is the stock-level entry point for investors researching Ironwood Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ironwood Pharmaceuticals, Inc. (ticker: IRWD) is a public company based in the United States, specializing in the development and commercialization of innovative therapies for gastrointestinal diseases. With a market capitalization of approximately $610.7 million, Ironwood focuses on addressing unmet medical needs in this area. The company is committed to improving patient outcomes through its research and product offerings.
- Ticker
- I76:BX
- Asset type
- Stock
- Market cap
- $674.2M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BX
- Currency
- CHF
Ironwood Pharmaceuticals, Inc. I76:BX stock context
This page tracks Ironwood Pharmaceuticals, Inc.'s I76:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following I76:BX. I76:BX is the stock-level entry point for investors researching Ironwood Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ironwood Pharmaceuticals, Inc. (ticker: IRWD) is a public company based in the United States, specializing in the development and commercialization of innovative therapies for gastrointestinal diseases. With a market capitalization of approximately $610.7 million, Ironwood focuses on addressing unmet medical needs in this area. The company is committed to improving patient outcomes through its research and product offerings.
Latest news from Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals to Participate in the Wells Fargo 21st Annual Healthcare Conference
September 3, 2026
Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results
August 6, 2026
Ironwood Pharmaceuticals to Host Second Quarter 2026 Investor Update Call
July 30, 2026
Ironwood Appoints Dr. Jeffrey Silber Chief Medical Officer and Head of Research and Drug Development; STARS-2 Trial Initiated in June and...
July 14, 2026
FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)
May 27, 2026
Ironwood Pharmaceuticals, Inc. earnings calls
Ironwood Pharmaceuticals, Inc. (IRWD) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Ironwood Pharmaceuticals, Inc. (IRWD) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2025 Earnings Call
February 25, 2026 · Replay with transcript and chapters
Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2024 Earnings Call
February 27, 2025 · Replay with transcript and chapters
Ironwood Pharmaceuticals, Inc. (IRWD) Q3 2024 Earnings Call
November 7, 2024 · Replay with transcript and chapters
Ironwood Pharmaceuticals, Inc. (IRWD) Q1 2024 Earnings Call
May 9, 2024 · Replay with transcript and chapters
Research Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for I76:BX.
Ironwood Pharmaceuticals, Inc. company profile
View the public company page for Ironwood Pharmaceuticals, Inc. on 6ix.
Ironwood Pharmaceuticals, Inc. news
Read company news and market updates connected to Ironwood Pharmaceuticals, Inc..
Ironwood Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Ironwood Pharmaceuticals, Inc..
Alternate listings
IRWD:NASDAQ
US · USD
Alternate listing for Ironwood Pharmaceuticals, Inc.; the primary context on this page is I76:BX.
I76:GETTEX
DE · EUR
Alternate listing for Ironwood Pharmaceuticals, Inc.; the primary context on this page is I76:BX.
IRWD:BOATS
US · USD
Alternate listing for Ironwood Pharmaceuticals, Inc.; the primary context on this page is I76:BX.
A0X789:LSX
DE · EUR
Alternate listing for Ironwood Pharmaceuticals, Inc.; the primary context on this page is I76:BX.
A0X789:LS
DE · EUR
Alternate listing for Ironwood Pharmaceuticals, Inc.; the primary context on this page is I76:BX.
I76:TRADEGATE
DE · EUR
Alternate listing for Ironwood Pharmaceuticals, Inc.; the primary context on this page is I76:BX.
I76:DUS
DE · EUR
Alternate listing for Ironwood Pharmaceuticals, Inc.; the primary context on this page is I76:BX.
I76:FWB
DE · EUR
Alternate listing for Ironwood Pharmaceuticals, Inc.; the primary context on this page is I76:BX.
I76:MUN
DE · EUR
Alternate listing for Ironwood Pharmaceuticals, Inc.; the primary context on this page is I76:BX.
I76:SWB
DE · EUR
Alternate listing for Ironwood Pharmaceuticals, Inc.; the primary context on this page is I76:BX.